US2014256645A1PendingUtilityA1

Extract and peptides derived from oryza sativa japonica group and uses thereof

Assignee: YISSUM RES DEV COPriority: Apr 11, 2010Filed: May 19, 2014Published: Sep 11, 2014
Est. expiryApr 11, 2030(~3.7 yrs left)· nominal 20-yr term from priority
Inventors:Uri Wormser
C07K 14/415C07K 7/08G01N 2800/285G01N 2333/415A61K 38/00C07K 7/06
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to isolated peptides derived from Oryza sativa Japonica Group, pharmaceutical compositions comprising same, and uses thereof for treating, preventing, ameliorating, and/or delaying the onset of inflammatory and/or neuroinflammatory and/or autoimmune diseases or conditions and in particular multiple sclerosis. The invention further relates to extracts from Oryza sativa Japonica Group and use thereof as a dietary supplement or in a pharmaceutical composition for treating, preventing, ameliorating, and/or delaying the onset of inflammatory, and/or inflammatory, neuroinflammatory and/or autoimmune diseases or conditions. The peptides and the extract of the invention may be used for treating, ameliorating, and/or delaying the onset or preventing multiple sclerosis.

Claims

exact text as granted — not AI-modified
1 . A method of treating, ameliorating, preventing or delaying the onset of multiple sclerosis in a subject comprising the step of administering to the subject a therapeutically effective amount of a composition comprising a peptide that comprises an amino acid sequence AEMIDLAAKMLSEGRG as set forth in SEQ ID NO: 1. 
     
     
         2 . The method of  claim 1 , wherein said composition is a pharmaceutical composition, an extract, or a dietary supplement. 
     
     
         3 . The method of  claim 1 , wherein said peptide is derived from  Oryza sativa  Japonica Group. 
     
     
         4 . The method of  claim 1 , wherein the amount of said peptide is between 1 fg/g to 1 mg/g. 
     
     
         5 . The method of  claim 2 , wherein said extract is further enriched by an exogenous peptide comprising the amino acid sequence AEMIDLAAKMLSEGRG as set forth in SEQ ID NO:1. 
     
     
         6 . A method of treating, ameliorating, preventing or delaying the onset of multiple sclerosis in a subject comprising the step of administering to the subject a therapeutically effective amount of a composition comprising a peptide consisting of an amino acid sequence AEMIDLAAKMLSEGRG as set forth in SEQ ID NO: 1. 
     
     
         7 . The method of  claim 6 , wherein said composition is a pharmaceutical composition, an extract, or a dietary supplement. 
     
     
         8 . The method of  claim 6 , wherein said peptide is derived from  Oryza sativa  Japonica Group. 
     
     
         9 . The method of  claim 6 , wherein the amount of said peptide is between 1 fg/g to 1 mg/g. 
     
     
         10 . The method of  claim 7 , wherein said extract is further enriched by an exogenous peptide comprising the amino acid sequence AEMIDLAAKMLSEGRG as set forth in SEQ ID NO:1.

Join the waitlist — get patent alerts

Track US2014256645A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.